<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" ID="P0b002ee18b3bc948">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm type="text" authority="marcrelator">publisher</roleTerm>
  <roleTerm type="code" authority="marcrelator">pbl</roleTerm>
</role>
 <role>
  <roleTerm type="text" authority="marcrelator">distributor</roleTerm>
  <roleTerm type="code" authority="marcrelator">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Congress</namePart>
 <namePart>Senate</namePart>
 <role>
  <roleTerm type="text" authority="marcrelator">author</roleTerm>
  <roleTerm type="code" authority="marcrelator">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>
<extension>
 <collectionCode>BILLS</collectionCode>
 <searchTitle>To amend the Controlled Substances Act and the Federal Food, Drug, and Cosmetic Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing, and for other purposes.;Improving Regulatory Transparency for New Medical Therapies Act;S. 481 (IS)</searchTitle>
 <category>Bills and Statutes</category>
 <waisDatabaseName>114_cong_bills</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2015-02-24</dateIngested>
</extension>
<titleInfo>
 <title>To amend the Controlled Substances Act and the Federal Food, Drug, and Cosmetic Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing, and for other purposes.</title>
</titleInfo>
<titleInfo type="alternative">
 <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
</titleInfo>
<titleInfo type="alternative">
 <title>S. 481 (IS)</title>
</titleInfo>
<originInfo>
 <publisher>U.S. Government Publishing Office</publisher>
 <dateIssued encoding="w3cdtf">2015-02-12</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>10 p.</extent>
</physicalDescription>
<classification authority="sudocs">Y 1.6:</classification>
<classification authority="sudocs">Y 1.4/1:</classification>
<identifier type="local">P0b002ee18b3bc948</identifier>
<identifier type="uri">https://www.gpo.gov/fdsys/pkg/BILLS-114s481is</identifier>
<identifier type="preferred citation">S. 481</identifier>
<identifier type="stock number">021-610-00252-9</identifier>
<identifier type="Parent ILS system id">000501532</identifier>
<identifier type="Child ILS system id">000325576</identifier>
<identifier type="Parent ILS title">Congressional bills</identifier>
<identifier type="Child ILS title">Senate bills</identifier>
<identifier type="former package identifier">f:s481_is.txt</identifier>
<location xmlns:exslt="http://exslt.org/common">
 <url access="object in context" displayLabel="Content Detail">https://www.gpo.gov/fdsys/pkg/BILLS-114s481is/content-detail.html</url>
 <url access="raw object" displayLabel="HTML rendition">https://www.gpo.gov/fdsys/pkg/BILLS-114s481is/html/BILLS-114s481is.htm</url>
 <url access="raw object" displayLabel="PDF rendition">https://www.gpo.gov/fdsys/pkg/BILLS-114s481is/pdf/BILLS-114s481is.pdf</url>
 <url access="raw object" displayLabel="XML rendition">https://www.gpo.gov/fdsys/pkg/BILLS-114s481is/xml/BILLS-114s481is.xml</url>
</location>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2015-02-24</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2016-10-13</recordChangeDate>
 <recordIdentifier source="DGPO">BILLS-114s481is</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<name type="personal">
 <namePart>Orrin G. Hatch</namePart>
 <affiliation>United States Senate</affiliation>
 <role>
  <roleTerm type="text" authority="marcrelator">sponsor</roleTerm>
  <roleTerm type="code" authority="marcrelator">spn</roleTerm>
</role>
 <description>United States Congress Member</description>
</name>
<name type="personal">
 <namePart>Sheldon Whitehouse</namePart>
 <affiliation>United States Senate</affiliation>
 <role>
  <roleTerm type="text">cosponsor</roleTerm>
</role>
 <description>United States Congress Member</description>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Congress</namePart>
 <namePart>Senate</namePart>
 <namePart>Committee on Health, Education, Labor, and Pensions</namePart>
 <role>
  <roleTerm type="text" authority="marcrelator">associated name</roleTerm>
  <roleTerm type="code" authority="marcrelator">asn</roleTerm>
</role>
</name>
<relatedItem xmlns:exslt="http://exslt.org/common" type="isReferencedBy">
 <titleInfo>
  <title>United States Code</title>
  <partNumber>Title 21 Section 355</partNumber>
  <partNumber>Title 21 Section 360b</partNumber>
  <partNumber>Title 21 Section 360ccc-1</partNumber>
  <partNumber>Title 21 Section 360ccc-2(c)</partNumber>
  <partNumber>Title 21 Section 360ccc(d)</partNumber>
  <partNumber>Title 21 Section 811</partNumber>
  <partNumber>Title 21 Section 823</partNumber>
</titleInfo>
 <identifier type="USC citation">21 U.S.C. 355</identifier>
 <identifier type="USC citation">21 U.S.C. 360b</identifier>
 <identifier type="USC citation">21 U.S.C. 360ccc-1</identifier>
 <identifier type="USC citation">21 U.S.C. 360ccc-2(c)</identifier>
 <identifier type="USC citation">21 U.S.C. 360ccc(d)</identifier>
 <identifier type="USC citation">21 U.S.C. 811</identifier>
 <identifier type="USC citation">21 U.S.C. 823</identifier>
</relatedItem>
<relatedItem xmlns:exslt="http://exslt.org/common" type="isReferencedBy">
 <titleInfo>
  <title>United States Code</title>
  <partNumber>Title 35 Section 156</partNumber>
</titleInfo>
 <identifier type="USC citation">35 U.S.C. 156</identifier>
</relatedItem>
<relatedItem xmlns:exslt="http://exslt.org/common" type="isReferencedBy">
 <titleInfo>
  <title>United States Code</title>
  <partNumber>Title 42 Section 262</partNumber>
</titleInfo>
 <identifier type="USC citation">42 U.S.C. 262</identifier>
</relatedItem>
<extension>
 <docClass>s</docClass>
 <accessId>BILLS-114s481is</accessId>
 <congress>114</congress>
 <session>1</session>
 <originChamber>SENATE</originChamber>
 <currentChamber>SENATE</currentChamber>
 <billNumber>481</billNumber>
 <billVersion reprint="false">is</billVersion>
 <fileSuffix>is</fileSuffix>
 <shortTitle type="measure">Improving Regulatory Transparency for New Medical Therapies Act</shortTitle>
 <officialTitle>To amend the Controlled Substances Act and the Federal Food, Drug, and Cosmetic Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing, and for other purposes.</officialTitle>
 <action date="2015-02-12">Mr. Hatch (for himself and Mr. Whitehouse) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions</action>
 <congCommittee authorityId="sshr00" chamber="S" congress="114" type="S">
                      <name type="authority-standard">Committee on Health, Education, Labor, and Pensions</name>
                      <name type="authority-short">HELP</name>
                </congCommittee>
 <congMember authorityId="1351" bioGuideId="H000338" chamber="S" congress="114" gpoId="8314" party="R" role="SPONSOR" state="UT">
                      <name type="parsed">Mr. Hatch</name>
                      <name type="authority-fnf">Orrin G. Hatch</name>
                      <name type="authority-lnf">Hatch, Orrin G.</name>
                      <name type="authority-other">Orrin Grant Hatch</name>
                </congMember>
 <congMember authorityId="1823" bioGuideId="W000802" chamber="S" congress="114" gpoId="8264" party="D" role="COSPONSOR" state="RI">
                      <name type="parsed">Mr. Whitehouse</name>
                      <name type="authority-fnf">Sheldon Whitehouse</name>
                      <name type="authority-lnf">Whitehouse, Sheldon</name>
                </congMember>
 <isPrivate>false</isPrivate>
 <isAppropriation>false</isAppropriation>
 <USCode title="21">
                      <section number="355"></section>
                      <section number="360b"></section>
                      <section number="360ccc-1"></section>
                      <section detail="(c)" number="360ccc-2"></section>
                      <section detail="(d)" number="360ccc"></section>
                      <section number="811"></section>
                      <section number="823"></section>
                </USCode>
 <USCode title="35">
                      <section number="156"></section>
                </USCode>
 <USCode title="42">
                      <section number="262"></section>
                </USCode>
</extension>
</mods>